Protection against genital tractChlamydia trachomatisinfection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen-Reference-Cited by-同舟云学术

Protection against genital tractChlamydia trachomatisinfection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen

Published:2016-11-18 Issue:12 Volume:124 Page:1078-1086
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:APMIS

Author:

Hadad Ronza¹²,Marks Ellen³,Kalbina Irina¹,Schön Karin³,Unemo Magnus²,Lycke Nils³,Strid Åke¹,Andersson Sören²

Affiliation:

1. Örebro Life Science Center; School of Science and Technology; Örebro University; Örebro Sweden

2. Department of Laboratory Medicine; Faculty of Medicine and Health; Örebro University; Örebro Sweden

3. Department of Medical Microbiology and Immunology; University of Gothenburg; Gothenburg Sweden

Funder

Sparbanksstiftelsen Nya

Stiftelsen Olle Engkvist Byggmästare

Universitetssjukhuset Örebro

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apm.12605/fullpdf

Reference44 articles.

1. World Health Organization, Department of Reproductive Health and Research Prevalence and incidence of selected sexually transmitted infections. Methods and results used by WHO to generate 2005 estimates Geneva World Health Organization 2011 http://apps.who.int/iris/bitstream/10665/75181/1/9789241503839_eng.pdf?ua=1

2. World Health Organization, Department of Reproductive Health and Research Global incidence and prevalence of selected curable sexually transmitted infections - 2008 Geneva World Health Organization 2012 http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimates.pdf

3. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1;Plummer;J Infect Dis,1991

4. Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada;Tuite;Sex Transm Dis,2012

5. Public health policies and management strategies for genital Chlamydia trachomatis infection;Shaw;Risk Manag Healthc Policy,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Chlamydia trachomatis Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs;Microorganisms;2024-06-13

2. Heterologous prime-boost vaccination based on Polymorphic protein D protects against intravaginal Chlamydia trachomatis infection in mice;Scientific Reports;2022-04-22

3. Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge;Frontiers in Immunology;2021-04-14

4. Lymphogranuloma venereum: an emerging problem in Poland;Advances in Dermatology and Allergology;2020

5. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance;PLOS ONE;2017-06-02